Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.
Palmer
Biff F
BF
Department of Medicine, Division of Nephrology, University of Texas Southwestern Medical School, Dallas 75390-8856, USA. biff.palmer@utsouthwestern.edu
D000450:Aldosterone / Q000097:blood / Q000378:metabolism; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced* / Q000517:prevention & control / Q000628:therapy*; D007668:Kidney / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D012084:Renin-Angiotensin System / Q000187:drug effects* / Q000502:physiology; D012307:Risk Factors; D012964:Sodium / Q000378:metabolism
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000450:Aldosterone; D012964:Sodium; D011188:Potassium